UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

AIDS (London), 2015-02, Vol.29 (4), p.463-471

2015

Volltextzugriff (PDF)

Persistent HIV-1 replication maintains the tissue reservoir during therapy

Nature (London), 2016-02, Vol.530 (7588), p.51-56

2016

Volltextzugriff (PDF)

Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection

PLoS pathogens, 2014-07, Vol.10 (7), p.e1004281

2014

Volltextzugriff (PDF)

Identification of Siglec-1 null individuals infected with HIV-1

Nature communications, 2016-08, Vol.7 (1), p.12412-7, Article 12412

2016

Volltextzugriff (PDF)

Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia

PLoS genetics, 2016-03, Vol.12 (3), p.e1005921-e1005921

2016

Volltextzugriff (PDF)

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients

Annals of hepatology, 2008-04, Vol.7 (2), p.152-156

2008

Volltextzugriff (PDF)

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.16-17

2020

Volltextzugriff (PDF)

Diagnostic Yields in Solid Organ Transplant Recipients Admitted With Diarrhea

Clinical infectious diseases, 2015-03, Vol.60 (5), p.729-737

2015

Volltextzugriff (PDF)

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1

Current HIV research, 2010-04, Vol.8 (3), p.194

2010

Volltextzugriff (PDF)

Pharmacodynamic effects in blood and tumor tissue of eftozanermin alfa, a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15668-e15668

2020

Volltextzugriff (PDF)

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-03, Vol.22 (2), p.300-311

2023

Volltextzugriff (PDF)

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy

Clinical infectious diseases, 2016-10, Vol.63 (8), p.1130-1139

2016

Volltextzugriff (PDF)

A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3015-3015

2021

Volltextzugriff (PDF)

Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets

Nature communications, 2023-09, Vol.14 (1), p.6030-6030, Article 6030

2023

Volltextzugriff (PDF)

Effect of Statin Use on Inflammation and Immune Activation Biomarkers in HIV-Infected Persons on Effective Antiretroviral Therapy

AIDS research and human retroviruses, 2021-05, Vol.37 (5), p.357

2021

Volltextzugriff (PDF)

Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients

Journal of acquired immune deficiency syndromes (1999), 2017-09, Vol.76 (1), p.e26

2017

Volltextzugriff (PDF)

Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co‐infected Nigerians

Tropical medicine & international health, 2017-06, Vol.22 (6), p.744-754

2017

Volltextzugriff (PDF)

Safety and efficacy of chronic suppressive azole therapy for endemic fungal infections in solid organ transplant recipients

Transplant infectious disease, 2018-10, Vol.20 (5), p.e12963-n/a

2018

Volltextzugriff (PDF)

First-in-Human Study of Abbv-621, a TRAIL Receptor Agonist Fusion Protein, in Patients (Pts) with Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML) and Diffuse Large B-Cell Lymphoma (DLBCL)

Blood, 2019-11, Vol.134 (Supplement_1), p.3924-3924

2019

Volltextzugriff (PDF)

The Association Between APOL1 Risk Alleles and Longitudinal Kidney Function Differs by HIV Viral Suppression Status

Clinical infectious diseases, 2015-02, Vol.60 (4), p.646-652

2015

Volltextzugriff (PDF)

Temporal Stability of Serum Concentrations of Cytokines and Soluble Receptors Measured Across Two Years in Low-Risk HIV-Seronegative Men

Cancer epidemiology, biomarkers & prevention, 2013-11, Vol.22 (11), p.2009-2015

2013

Volltextzugriff (PDF)

1164. Epidemiology of Cryptococcal Infections in Non-HIV Patients: A 20-year Single Center Experience

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S608-S608

2020

Volltextzugriff (PDF)

1212 AFVT-2101, an innate immune-cell engager that selectively targets FOLR1 expressing tumor cells to safely harness potent anti-cancer responses

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A1257-A1257

2022

Volltextzugriff (PDF)

Optimal strategies for the diagnosis of community‐onset diarrhea in solid organ transplant recipients: Less is more

Transplant infectious disease, 2017-04, Vol.19 (2), p.n/a

2017

Volltextzugriff (PDF)

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death

Journal of neurovirology, 2015-02, Vol.21 (1), p.24-31

2015

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

Persistent HIV-1 replication maintains the tissue reservoir during therapy

Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection

Identification of Siglec-1 null individuals infected with HIV-1

Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Diagnostic Yields in Solid Organ Transplant Recipients Admitted With Diarrhea

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1

Pharmacodynamic effects in blood and tumor tissue of eftozanermin alfa, a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy

A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results

Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets

Effect of Statin Use on Inflammation and Immune Activation Biomarkers in HIV-Infected Persons on Effective Antiretroviral Therapy

Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients

Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co‐infected Nigerians

Safety and efficacy of chronic suppressive azole therapy for endemic fungal infections in solid organ transplant recipients

First-in-Human Study of Abbv-621, a TRAIL Receptor Agonist Fusion Protein, in Patients (Pts) with Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML) and Diffuse Large B-Cell Lymphoma (DLBCL)

The Association Between APOL1 Risk Alleles and Longitudinal Kidney Function Differs by HIV Viral Suppression Status

Temporal Stability of Serum Concentrations of Cytokines and Soluble Receptors Measured Across Two Years in Low-Risk HIV-Seronegative Men

1164. Epidemiology of Cryptococcal Infections in Non-HIV Patients: A 20-year Single Center Experience

1212 AFVT-2101, an innate immune-cell engager that selectively targets FOLR1 expressing tumor cells to safely harness potent anti-cancer responses

Optimal strategies for the diagnosis of community‐onset diarrhea in solid organ transplant recipients: Less is more

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death

Suchergebnisse filtern